| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 43.096 | 89.213 | 46.187 | 271.682 | 1.003.443 | 749.577 | 312.689 | 307.250 | 873.705 | 306.907 |
| Total Income - EUR | 43.097 | 89.216 | 46.188 | 271.683 | 1.003.983 | 749.623 | 312.705 | 307.283 | 874.133 | 315.220 |
| Total Expenses - EUR | 23.515 | 49.667 | 27.413 | 174.054 | 741.151 | 492.046 | 160.377 | 159.541 | 546.165 | 197.610 |
| Gross Profit/Loss - EUR | 19.582 | 39.549 | 18.775 | 97.628 | 262.833 | 257.577 | 152.327 | 147.742 | 327.967 | 117.610 |
| Net Profit/Loss - EUR | 18.289 | 36.873 | 17.390 | 94.414 | 254.273 | 251.534 | 149.526 | 144.731 | 288.122 | 100.093 |
| Employees | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Eldiro Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 1.181 | 13.792 | 69.265 | 5.708 | 7.344 | 6.546 | 10.318 | 16.286 |
| Current Assets | 36.187 | 73.397 | 88.762 | 256.593 | 1.250.591 | 797.898 | 894.097 | 544.063 | 438.347 | 426.742 |
| Inventories | 0 | 0 | 0 | 0 | 231.827 | 106.257 | 74.575 | 181.241 | 12.331 | 0 |
| Receivables | 6.578 | 2.716 | 5.825 | 15.210 | 260.496 | 441.517 | 169.609 | 20.248 | 22.644 | 12.646 |
| Cash | 29.608 | 70.681 | 82.937 | 241.383 | 758.267 | 250.124 | 649.912 | 342.574 | 403.371 | 414.097 |
| Shareholders Funds | 35.800 | 72.308 | 88.474 | 181.264 | 432.027 | 675.371 | 809.919 | 421.470 | 426.083 | 403.612 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 387 | 1.089 | 1.469 | 89.122 | 887.829 | 128.235 | 91.521 | 129.139 | 22.582 | 39.417 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Eldiro Medical Srl